GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $20,010,000 | +11.4% | 500,000 | +16.3% | 2.74% | +66.9% |
Q1 2019 | $17,970,000 | +51.7% | 430,000 | +38.7% | 1.64% | +22.8% |
Q4 2018 | $11,845,000 | -65.9% | 310,000 | -64.2% | 1.34% | -66.5% |
Q3 2018 | $34,747,000 | +12.7% | 865,000 | +13.1% | 3.99% | -6.2% |
Q2 2018 | $30,837,000 | +57.9% | 765,000 | +53.0% | 4.25% | +43.3% |
Q1 2018 | $19,535,000 | +22.4% | 500,000 | +11.1% | 2.97% | +58.4% |
Q4 2017 | $15,962,000 | -12.6% | 450,000 | 0.0% | 1.87% | -28.2% |
Q3 2017 | $18,270,000 | -5.8% | 450,000 | 0.0% | 2.61% | -20.9% |
Q2 2017 | $19,404,000 | +203.6% | 450,000 | +13.0% | 3.30% | +98.7% |
Q2 2016 | $6,391,000 | +52.3% | 398,287 | +305.6% | 1.66% | +132.0% |
Q4 2014 | $4,197,000 | -6.0% | 98,200 | +1.1% | 0.72% | +29.8% |
Q3 2014 | $4,464,000 | -72.2% | 97,100 | -67.6% | 0.55% | -86.1% |
Q2 2014 | $16,044,000 | -53.8% | 300,000 | -53.8% | 3.95% | -50.1% |
Q1 2014 | $34,730,000 | +18.3% | 650,000 | +18.2% | 7.93% | -3.1% |
Q4 2013 | $29,365,000 | – | 550,000 | – | 8.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |